These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 38618935)
1. AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Castro B; Steel JC; Layton CJ Expert Rev Mol Med; 2024 Apr; 26():e9. PubMed ID: 38618935 [TBL] [Abstract][Full Text] [Related]
2. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies. Castro BFM; Steel JC; Layton CJ BioDrugs; 2024 Jan; 38(1):73-93. PubMed ID: 37878215 [TBL] [Abstract][Full Text] [Related]
3. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution. Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC Elife; 2021 Oct; 10():. PubMed ID: 34664552 [TBL] [Abstract][Full Text] [Related]
4. [Aiming for zero blindness]. Nakazawa T Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109 [TBL] [Abstract][Full Text] [Related]
5. [Advancements in research on immune responses associated with adeno-associated virus vector-mediated ocular gene therapy]. Zhu XL; Zhang BN; Xie LX Zhonghua Yan Ke Za Zhi; 2024 Mar; 60(3):289-295. PubMed ID: 38462380 [TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies. Xia X; Guo X Front Med (Lausanne); 2023; 10():1310050. PubMed ID: 38105897 [TBL] [Abstract][Full Text] [Related]
7. AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis. Crabtree E; Song L; Llanga T; Bower JJ; Cullen M; Salmon JH; Hirsch ML; Gilger BC Sci Rep; 2019 Dec; 9(1):19864. PubMed ID: 31882729 [TBL] [Abstract][Full Text] [Related]
8. Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure. Yue J; Khan RS; Duong TT; Dine KE; Cui QN; O'Neill N; Aravand P; Liu T; Chaqour B; Shindler KS; Ross AG Neurotherapeutics; 2023 Apr; 20(3):896-907. PubMed ID: 36941497 [TBL] [Abstract][Full Text] [Related]
9. Immune responses to retinal gene therapy using adeno-associated viral vectors - Implications for treatment success and safety. Bucher K; Rodríguez-Bocanegra E; Dauletbekov D; Fischer MD Prog Retin Eye Res; 2021 Jul; 83():100915. PubMed ID: 33069860 [TBL] [Abstract][Full Text] [Related]
10. [Glaucoma and uveitis. Causes of and treatment options for increased intraocular pressure in cases of inflammatory ophthalmology]. Dietlein TS Ophthalmologe; 2003 Nov; 100(11):991-1006; quiz 1007-8. PubMed ID: 14708525 [TBL] [Abstract][Full Text] [Related]
11. Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9. Wu J; Bell OH; Copland DA; Young A; Pooley JR; Maswood R; Evans RS; Khaw PT; Ali RR; Dick AD; Chu CJ Mol Ther; 2020 Mar; 28(3):820-829. PubMed ID: 31981492 [TBL] [Abstract][Full Text] [Related]
13. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism. Woodard KT; Liang KJ; Bennett WC; Samulski RJ J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice. Tummala G; Crain A; Rowlan J; Pepple KL Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):41. PubMed ID: 33630023 [TBL] [Abstract][Full Text] [Related]
15. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization. Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. Borrás T; Xue W; Choi VW; Bartlett JS; Li G; Samulski RJ; Chisolm SS J Gene Med; 2006 May; 8(5):589-602. PubMed ID: 16506246 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma. Starr C; Chen B Vision Res; 2023 May; 206():108196. PubMed ID: 36812679 [TBL] [Abstract][Full Text] [Related]
18. [Recent advances in gene therapy of uveitis]. Tao XY; Yang PZ; Lei B Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):281-4. PubMed ID: 23866711 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye. Gilger BC; Hirsch ML Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408825 [TBL] [Abstract][Full Text] [Related]
20. Glaucoma: genes, phenotypes, and new directions for therapy. Fan BJ; Wiggs JL J Clin Invest; 2010 Sep; 120(9):3064-72. PubMed ID: 20811162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]